Extracellular nucleotide inhibits cell proliferation and negatively regulates Toll-like receptor 4 signalling in human progenitor endothelial cells

Cell Biology International

Volumn 36, Issue 7, 2012, Pages 625-633

  Xiao, Zhilin ^a   Yang, Mei ^a   Fang, Li ^a   Lv, Qingshan ^a   He, Qing ^b   Deng, Minjie ^b   Liu, Xueting ^b   Chen, Xiaobin ^a   Chen, Meifang ^a   Xie, Xiumei ^a   Hu, Jinyue ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

ATP; Endothelial progenitor cell (EPC); P2y2; Proliferation; Toll like receptor 4 (TLR4) signalling; UTP

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA INTERFERON; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC P2Y14 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UMBILICAL CORD BLOOD; UPREGULATION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD14; CELL PROLIFERATION; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION; HUMANS; LIPOPOLYSACCHARIDES; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORYLATION; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; STEM CELLS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UMBILICAL CORD; URIDINE TRIPHOSPHATE;

EID: 84862893606     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110111     Document Type: Article

References (41)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C et al. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006;58:281-341.
2. Akira S, Takeda K, Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
3. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
4. Aoki M, Yasutake M, Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 2004;22:994-1002.
5. Butchar JP, Parsa KV, Marsh CB, Tridandapani S. Negative regulators of toll-like receptor 4-mediated macrophage inflammatory response. Curr Pharm Des 2006;12:4143-53.
6. Coppi E, Pugliese AM, Urbani S, Melani A, Cerbai E, Mazzanti B. ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells 2007;25:1840-9.
7. Dauphinee, SM. Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest 2006;86:9-22.
8. Degagné E, Grbic DM, Dupuis AA, Lavoie EG, Langlois C, Jain N et al. P2Y(2) Receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE(2) released by intestinal epithelial cells. J Immunol 2009;183:4521-9.
9. Diwan, A. Dorn, GW. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 2007;22:56-64.
10. Draper DW, Madenspacher JH, Dixon D, King DH, Remaley AT, Fessler MB. ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung. Am J Respir Crit Care Med 2009;179:A1022.
11. Edfeldt K, Swedenborg J, Hansson GK, Yan Z-Q. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002;105:1158-61.
12. Feng CL, Mery AG, Beller EM, Favot C, Boyce JA. Adenine nucleotides inhibit cytokine generation by human mast cells through a GScoupled receptor. J Immunol 2004;173:7539-47.
13. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006;176:3877-83.
14. He J, Xiao Z, Chen X, Chen M, Fang L, Yang M et al. The expression of functional toll-like receptor 4 is associated with proliferation and maintenance of stem cell phenotype in endothelial progenitor cells (EPCs). J Cell Biochem 2010;111:179-86.
15. Heo JS, Han HJ. ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways. Stem Cells 2006;24:2637-48.
16. Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA et al. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1998;273:27170-5.
17. Korcok J, Raimundo LN, Du X, Sims SM, Dixon SJ. P2Y6 nucleotide receptors activate NF-kappa B and increase survival of osteoclasts. J Biol Chem 2005;280:16909-15
18. Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, Choi S. Toll-like receptor signal transduction. Exp Mol Med 2007;39:421-38.
19. Lall H, Coughlan K, Sumbayev VV. HIF-1 alpha protein is an essential factor for protection of myeloid cells against LPS-induced depletion of ATP and apoptosis that supports Toll-like receptor 4-mediated production of IL-6. Mol Immunol 2008;45:3045-9.
20. Lang T, Mansell A. The negative regulation of toll-like receptor and associated pathways. Immunol Cell Biol 2007;85:425-34.
21. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005;5:446-58.
22. Marteau F, Communi D, Boeynaems JM, Suarez Gonzalez N. Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells. J Leukocyte Biol 2004;76:796-803.
23. Mbalaviele G, Sommers CD, Bonar SL, Mathialagan S, Schindler JF, Guzova JA et al. A novel, highly selective, tight binding I kappa B Kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappa B pathway in arthritis-relevant cells and animal models. J Pharmacol Exp Ther 2009;329:14-25.
24. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Tolllike receptor 4-dependent and -independent cytokine secretion secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005;25:1213-9.
25. Mishra SK, Braun N, Shukla V, Fullgrabe M, Schomerus C, Korf HW et al. Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development 2005;133:675-84.
26. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000;105:1527-36.
27. Nalos M, Huang S, Sluyter R, Khan A, Santner-Nanan B, Nanan R et al. Host tissue damage' signal ATP impairs IL-12 and IFN gamma secretion in LPS stimulated whole human blood. Intensive Care Med 2008;34:1891-7.
28. Opitz B, Eitel J, Meixenberger K, Suttorp N. Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections. Thromb Haemostasis 2009;102:1103-9.
29. Opitz B, Hippenstiel S, Eitel J, Suttorp N. Extra- and intracellular innate immune recognition in endothelial cells. Thromb Haemostasis 2007;98:319-26.
30. Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA 2008;105:8067-72.
31. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R et al. The extracellular nucleotide UTP is a potent inducer of haematopoietic stem cell migration. Blood 2007;109:533-42.
32. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukocyte Biol 2008;83:536-45.
33. Silva CG, Specht A, Wegiel B, Ferran C, Kaczmarek E. Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation 2009;119;871-9.
34. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2006;89:E1-7.
35. Vincent FM, Richard TL. Stem-cell therapy for cardiac disease. Nature 2008;451:937-42.
36. Virgilio FD, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001;97:587.
37. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells, limitations for therapy. Arterioscler Thromb Biol 2006;26: 257-66.
38. West AP, Koblansky AA, Ghosh S. Recognition and signaling by toll-like receptors. Ann Rev Cell Dev Biol 2006;22:409-37.
39. Yamamoto, M. Akira S. Lipid a receptor TLR4-mediated signaling pathways. Adv Exp Med Biol 2009;667:59-68.
40. Ye X, Ding J, Zhou X. Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis. J Exp Med 2008;205:1303-15.
41. Zlatkovic-Lindor J, Arrell DK, Yamada S, Nelson TJ, Terzic A. ATP-sensitive K+channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy. Stem Cells 2010;28:1355-67.